G, W., XL, D., R, L., FR, J., JT, L., & LB, L. (2026). Mitochondrial Dysfunction in Parkinson's Disease: Diagnostic and Therapeutic Advances. CNS & neurological disorders drug targets. https://doi.org/10.2174/0118715273454275260601070029
Chicago Style (17th ed.) CitationG, Wu, Dong XL, Li R, Jin FR, Lu JT, and Lin LB. "Mitochondrial Dysfunction in Parkinson's Disease: Diagnostic and Therapeutic Advances." CNS & Neurological Disorders Drug Targets 2026. https://doi.org/10.2174/0118715273454275260601070029.
MLA (9th ed.) CitationG, Wu, et al. "Mitochondrial Dysfunction in Parkinson's Disease: Diagnostic and Therapeutic Advances." CNS & Neurological Disorders Drug Targets, 2026, https://doi.org/10.2174/0118715273454275260601070029.
Warning: These citations may not always be 100% accurate.